How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in...
Regulatory decision-making depends on evidence that reflects how medical products perform in...
When two federal agencies, the National Center for Science and Engineering Statistics (NCSES) and...
Government health agencies are increasingly turning to real-world data (RWD) for public health...
A new peer-reviewed study from the Centers for Disease Control and Prevention (CDC) highlights the...
Author: Emery Niemiec, Director, Partners & Alliance at HealthVerity Privacy preserving record...
Rare diseases may be individually uncommon, but collectively they affect an estimated 30 million people in the United States. Yet for many patients, the path to diagnosis spans years, sometimes decades. Symptoms appear one at a time. Specialists trea...